432 related articles for article (PubMed ID: 9606609)
1. What do animal cancer tests tell us about human cancer risk?: Overview of analyses of the carcinogenic potency database.
Gold LS; Slone TH; Ames BN
Drug Metab Rev; 1998 May; 30(2):359-404. PubMed ID: 9606609
[TBL] [Abstract][Full Text] [Related]
2. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
3. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
[TBL] [Abstract][Full Text] [Related]
4. Prediction of carcinogenicity from two versus four sex-species groups in the carcinogenic potency database.
Gold LS; Slone TH
J Toxicol Environ Health; 1993 May; 39(1):143-57. PubMed ID: 8492327
[TBL] [Abstract][Full Text] [Related]
5. Supplement to the Carcinogenic Potency Database (CPDB): results of animal bioassays published in the general literature through 1997 and by the National Toxicology Program in 1997-1998.
Gold LS; Manley NB; Slone TH; Rohrbach L; Garfinkel GB
Toxicol Sci; 2005 Jun; 85(2):747-808. PubMed ID: 15800034
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological and experimental applications to occupational cancer prevention.
Vainio H; Hemminki K
J UOEH; 1989 Mar; 11 Suppl():323-45. PubMed ID: 2664947
[TBL] [Abstract][Full Text] [Related]
7. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
8. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
Walker VE; Meng Q
Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
[TBL] [Abstract][Full Text] [Related]
9. Chloroform mode of action: implications for cancer risk assessment.
Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA
Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278
[TBL] [Abstract][Full Text] [Related]
10. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
11. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
[TBL] [Abstract][Full Text] [Related]
12. The results of assays in Drosophila as indicators of exposure to carcinogens.
Vogel EW; Graf U; Frei HJ; Nivard MM
IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
[TBL] [Abstract][Full Text] [Related]
13. Supplement to the Carcinogenic Potency Database (CPDB): results of animal bioassays published in the general literature in 1993 to 1994 and by the National Toxicology Program in 1995 to 1996.
Gold LS; Manley NB; Slone TH; Rohrbach L
Environ Health Perspect; 1999 Aug; 107 Suppl 4(Suppl 4):527-600. PubMed ID: 10421768
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
Kirkland D; Aardema M; Henderson L; Müller L
Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
[TBL] [Abstract][Full Text] [Related]
15. The Carcinogenic Potency Database: analyses of 4000 chronic animal cancer experiments published in the general literature and by the U.S. National Cancer Institute/National Toxicology Program.
Gold LS; Slone TH; Manley NB; Garfinkel GB; Hudes ES; Rohrbach L; Ames BN
Environ Health Perspect; 1991 Dec; 96():11-5. PubMed ID: 1820251
[TBL] [Abstract][Full Text] [Related]
16. Environmental and chemical carcinogenesis.
Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
[TBL] [Abstract][Full Text] [Related]
17. Comparison of target organs of carcinogenicity for mutagenic and non-mutagenic chemicals.
Gold LS; Slone TH; Stern BR; Bernstein L
Mutat Res; 1993 Mar; 286(1):75-100. PubMed ID: 7678909
[TBL] [Abstract][Full Text] [Related]
18. Multiple steps in carcinogenesis, multiple carcinogenic factors, and multiple primary tumors: can we develop an appropriate response for cancer prevention?
Nagao M; Sugimura T
Drug Metab Rev; 1998 May; 30(2):405-19. PubMed ID: 9606610
[No Abstract] [Full Text] [Related]
19. Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity.
Zeiger E
Cancer Res; 1987 Mar; 47(5):1287-96. PubMed ID: 3815340
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the carcinogenic risk of environmental chemicals].
Ito N; Imaida K; Ogiso T; Tamano S; Kurata Y
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3345-53. PubMed ID: 3789750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]